Cancer researchers today announced they have developed a way of sidelining one of the most dangerous “bad actors” in leukemia. Their approach depends on throwing a molecular wrench into the gears of an important machine that sets genes into motion, enabling cancer cells to proliferate.
In 2016 alone, 58,320 people in the U.S. died from leukemia. This new development could increase a patients’ chance of survival Current treatment methods can increase a patient’s risk of secondary cancer after remission. This Engineered T-Cell approach has not shown to be carcinogenic
A new molecule multiplies stem cells in umbilical cord blood. More blood-making stem cells could mean more effective transplants for people with blood cancers.